Stefan HE businessman

from Wikipedia, the free encyclopedia
Stefan HE Kaufmann, December 2018

Stefan Hugo Ernst Kaufmann (born June 8, 1948 in Ludwigshafen am Rhein ) is a German biologist .

Life

Kaufmann received his doctorate in 1977 from the University of Mainz and qualified as a professor in 1981 for immunology and microbiology at the Free University of Berlin . In Mainz he was a student of the immunologist Paul Klein .

From 1987 to 1991 he was Professor (C 3) for Medical Microbiology and Immunology at the University of Ulm and from 1991 to 1998 Professor (C 4) at the Department of Immunology at the same university. Since 1993 he has been director (since 2019 emeritus director) at the Berlin Max Planck Institute for Infection Biology , where he was one of the founding directors. Since 2018 he has been a Faculty Fellow of the Hagler Institute for Advanced Study at Texas A&M University . He has also been Professor of Microbiology and Immunology at the Charité in Berlin since 1998 .

Kaufmann is a collector of medical history works.

Act

Kaufmann has published more than 900 original scientific papers and reviews and, according to the Institute for Scientific Information, is one of the most cited immunologists worldwide with more than 70,000 citations ( Google Scholar ). He is among the 0.01% most cited scientists of around 7 million scientists from the 22 most important scientific fields worldwide.

His current scientific interest focuses on the deciphering of the cell-mediated immune response against intracellular bacteria , the development and testing of a new and improved vaccine against tuberculosis as well as biomarkers for the reliable diagnosis of the course and onset of the disease. A vaccine against tuberculosis developed by him is currently in clinical review. Clinical study (NCT 03152903). The vaccine is currently being tested to prevent recurrence in a phase III study (NCT 03152903) and to prevent tuberculosis disease in household contacts of tuberculosis patients in India. Treatment of bladder cancer with the vaccine has shown extremely promising results in a clinical review (NCT 02371447). Now the vaccine is to be tested in clinical studies to strengthen the innate immunity to defend against SARS-CoV-2 and Covid-19. He continues to work intensively for a better understanding of immunology and infectious diseases in the public (EFIS - Day of Immunology).

From 2010 to 2013, Kaufmann was an alternate member of the Advisory Board of the Global Alliance for Vaccines and Immunization (GAVI). From 2009 to 2014 he was a member of the Scientific Advisory Board of the Global Alliance for TB Drug Development (TB Alliance), New York. Since 2014 he has been a member of the Strategic Advisory Committee of the European & Developing Countries Clinical Trials Partnership (EDCTP). Kaufmann is a member of the Executive Board and the Scientific Advisory Board of the Robert Koch Foundation , which annually awards the Robert Koch Prize and the Robert Koch Gold Medal. He has been Chairman of the Board of Trustees of the Schering Foundation since 2014. From 2013 to 2014 he was a corresponding member and since 2014 he has been a full member of the Board of Trustees for the Lindau Nobel Laureate Meetings.

honors and awards

For his scientific work on infectious immunology of bacterial pathogen Listeria monocytogenes and Mycobacterium tuberculosis , he has received numerous awards, among others, in 1982 with the award of the German Society for Hygiene and Microbiology , 1987, Alfried Krupp -Förderpreis for Young Professors, 1988, Aronson Prize of State of Berlin, 1991 with the Smith Kline Beecham Science Award , 1991 with the Merckle Research Award, 1992 with the Robert Pfleger Research Award, 1992 with the Pettenkofer Award, 1993 with the main award of the German Society for Hygiene and Microbiology (DGHM). In 2007 he received the Doctor Honoris Causa from the University of the Mediterranean Aix-Marseille II , France, in 2014 the Gardner Middlebrook Award, and in 2018 the Gagna A. & Ch. Van Heck Prize. He is a Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin).

Since 1998 he has been a member of the Berlin-Brandenburg Academy of Sciences, since 2000 a member of the Deutsche Akademie der Naturforscher Leopoldina, Halle, since 1996 a member of the American Academy of Microbiology and since 2012 a member of the European Molecular Biology Organization (EMBO). He is also a member of various other scientific societies, former president and honorary member of the German Society for Immunology (DGfI), former president of the European Federation of Immunological Societies (EFIS) and former president of the national Union of Immunological Societies (IUIS).

Fonts (selection)

  • The fight between humans and microbes. Audio CDs. supposé, Cologne 2006, ISBN 3-932513-69-X .
  • Is the risk of epidemics growing? Global epidemics and poverty. Strategies for Containing Disease in a Connected World. With the collaboration of Susan Schädlich. Edited by Klaus Wiegandt . [Forum for Responsibility]. Fischer Taschenbuch Verlag, Frankfurt 2008, ISBN 978-3-596-17664-9 .
  • Epidemics: knowing what's right. Herder, Freiburg im Breisgau 2010, ISBN 978-3-451-06102-8 .
  • Tuberculosis - Example of Partnerships. Worldh Health Summit In: Deutsches Ärzteblatt. Volume 106, issue 42 (2009).
  • The New Plagues: Pandemics and Poverty in a Globalized World. The Sustainability Project, Haus Publishing, London 2009, ISBN 978-1-906598-13-6 .
  • with Paul van Helden, Eric Rubin and Warwick J. Britton (eds.): Handbook of Tuberculosis. 3 volumes, ISBN 978-3-527-31683-0 .
  • with Bruce D. Walker (Ed.): AIDS and Tuberculosis, A Deadly Liaison. (Infection Biology Series). Wiley-VCH, Weinheim, ISBN 978-3-527-32270-1 .
  • with Barry T. Rouse and David L. Sacks (Eds.): The Immune Response to Infection. ASM Press, 2011, ISBN 978-1-55581-514-1 .
  • Bio-signature of tuberculosis. In: Management & Hospital. No. 6, p. 27. (www.management-krankenhaus.de/topstories/labor-diagnostik/bio-signatur-der-tuberkulose)
  • When microbes get bad. In: Cicero. Magazine. Edition July 2011, pp. 42–43 (www.cicero.de/salon/wenn-mikroben-böse-haben/42323)
  • Basic knowledge of immunology. Springer textbook, Springer Verlag, 2014, ISBN 978-3-642-40324-8 .
  • Alexander Riedel: portrait, Der Tagesspiegel, heads, 100th edition, pp. 116, 2016

Web links

Videos

Individual evidence

  1. ↑ Class of 2018-19 Faculty Fellows , at hias.tamu.edu, accessed on May 12, 2020
  2. ↑ Portrait of Stefan HE Kaufmann , on background.tagesspiegel.de, accessed on May 12, 2020
  3. ^ Ingrid Brunner: The epidemics of tomorrow . In: Süddeutsche Zeitung . April 28, 2020 ( sueddeutsche.de [accessed May 12, 2020]).
  4. ^ Sabine Rosenbladt: Curiosity and Bacilli. In: Cicero . January 2011, pp. 136-138.
  5. ↑ PLoS Biol 17 (8): e3000384, 2019
  6. ↑ New hope for a better tuberculosis vaccine. on: handelsblatt.com
  7. ↑ Taking a New Shot at a TB Vaccine. In: Science. 16 December 2011: Vol. 334 no. 6062, pp. 1488–1490, doi : 10.1126 / science.334.6062.1488
  8. ↑ Syringe against consumption. In: Der Spiegel. 20/2012, Medicine, p. 118.
  9. ↑ TB vaccine trial on adults begins in June. in: thehindu.com
  10. ↑ Revamped, safer, and with greater punch. in: thehindu.com
  11. ↑ ICMR begins trials on vaccine for close contacts of TB patients. in: The Hindu BusinessLine
  12. ↑ Modified tuberculosis vaccine as a therapy against bladder cancer. , at mpiib-berlin.mpg.de
  13. ↑ Has this Max Planck researcher found corona protection? , In: Der Spiegel. 14/2020
  14. ↑ "EFIS - Day of Immunology"
  15. ↑ "Portrait - Courage to do something"
  16. ↑ GAGNA A. & Ch. VAN HECK Prize - 2018 , website of the Fonds National de la Recherche Scientifique, accessed on August 3, 2018.
  17. ↑ Member entry by Prof. Dr. Stefan HE Kaufmann (with picture and CV) at the German Academy of Natural Scientists Leopoldina , accessed on July 15, 2016.
personal data
SURNAME Kaufmann, Stefan HE
ALTERNATIVE NAMES Businessman, Stefan Hugo Ernst
BRIEF DESCRIPTION German biologist
DATE OF BIRTH June 8, 1948
PLACE OF BIRTH Ludwigshafen am Rhein